Assembly Biosciences Inc (ASMB) — Cash Flow Reinvestment Rate

Latest as of December 2023: 1.22x

Assembly Biosciences Inc (ASMB) has a Cash Flow Reinvestment Rate of 1.22x as of December 2023, reinvesting $89.72 Million (capex $71.00K plus investments $-89.65 Million) from operating cash flow of $73.65 Million. Explore ASMB capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

1.22x
(Capex + Investments) / Operating CF

Total Reinvested

$89.72 Million
Capex + Investments

Operating Cash Flow

$73.65 Million
USD

Capital Expenditures

$71.00K
USD

Assembly Biosciences Inc Cash Flow Reinvestment Rate (2017–2023)

Historical reinvestment intensity for Assembly Biosciences Inc across 2 annual periods. Also explore how large is Assembly Biosciences Inc's balance sheet for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Assembly Biosciences Inc (2017–2023)

Year-by-year capital reinvestment analysis for Assembly Biosciences Inc. For live market cap and broader valuation context, see how much is Assembly Biosciences Inc worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2023 1.64x $37.33 Million $22.74 Million $255.00K ▼ -80.5%
2017 8.41x $15.64 Million $1.86 Million $864.56K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow